The detection of novelty relies on dopaminergic signaling: evidence from apomorphine's impact on the novelty N2

M. Rangel-Gomez, C.M. Hickey, T.A.M.J. van Amelsvoort, P.M. Bet, M. Meeter

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Scopus)

Abstract

Despite much research, it remains unclear if dopamine is directly involved in novelty detection or plays a role in orchestrating the subsequent cognitive response. This ambiguity stems in part from a reliance on experimental designs where novelty is manipulated and dopaminergic activity is subsequently observed. Here we adopt the alternative approach: we manipulate dopamine activity using apomorphine (D1/D2 agonist) and measure the change in neurological indices of novelty processing. In separate drug and placebo sessions, participants completed a von Restorff task. Apomorphine speeded and potentiated the novelty-elicited N2, an Event-Related Potential (ERP) component thought to index early aspects of novelty detection, and caused novel-font words to be better recalled. Apomorphine also decreased the amplitude of the novelty-P3a. An increase in D1/D2 receptor activation thus appears to potentiate neural sensitivity to novel stimuli, causing this content to be better encoded. © 2013 Rangel-Gomez et al.
Original languageEnglish
Article numbere66469
JournalPLOS ONE
Volume8
Issue number6
DOIs
Publication statusPublished - 2013

Cite this